Oregon House, CA, United States of America

Arthur L Craigmill

This inventor holds 1 USPTO granted patent. Top assignee: North Carolina State University. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur L Craigmill. Retrieved from https://idiyas.com/inventor/arthur-l-craigmill

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arthur L Craigmill: Innovator in Drug Withdrawal Interval Determination

Introduction

Arthur L Craigmill is an accomplished inventor based in Oregon House, California. He has made significant contributions to the field of pharmacology, particularly in the area of drug withdrawal intervals. His innovative approach has the potential to enhance the safety and efficacy of drug use in various jurisdictions.

Latest Patents

Arthur L Craigmill holds a patent for "Methods, systems and products for determining drug withdrawal intervals." This invention provides a method for estimating a withdrawal interval for an adjusted dose of a compound based on prior withdrawal times, half-life data, and tolerance concentrations. The process is particularly useful for determining withdrawal intervals for extralabel drug uses, ensuring compliance with regulations across different jurisdictions.

Career Highlights

Craigmill is affiliated with North Carolina State University, where he continues to engage in research and development. His work focuses on improving drug safety and compliance, which is critical in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues such as Jim E Riviere and Tomas Martin-Jimenez, contributing to advancements in drug research and safety protocols.

Conclusion

Arthur L Craigmill's innovative work in determining drug withdrawal intervals showcases his commitment to enhancing pharmaceutical practices. His contributions are vital for ensuring drug safety and compliance across various jurisdictions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…